TRAF3 and plasma cell myeloma: Deletions and mutations of TRAF3 have been reported in multiple myeloma [294-296], Waldenström’s macroglobulinemia [300], Hodgkin lymphomas (HLs) [301], and a variety of non-Hodgkin lymphomas (NHLs), including splenic marginal zone lymphoma, B cell chronic lymphocytic leukemia (B-CLL), and mantle cell lymphoma [298,299].